B.H.E. Jansen

790 total citations
30 papers, 537 citations indexed

About

B.H.E. Jansen is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Rheumatology. According to data from OpenAlex, B.H.E. Jansen has authored 30 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 15 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Rheumatology. Recurrent topics in B.H.E. Jansen's work include Prostate Cancer Treatment and Research (24 papers), Prostate Cancer Diagnosis and Treatment (19 papers) and Radiopharmaceutical Chemistry and Applications (12 papers). B.H.E. Jansen is often cited by papers focused on Prostate Cancer Treatment and Research (24 papers), Prostate Cancer Diagnosis and Treatment (19 papers) and Radiopharmaceutical Chemistry and Applications (12 papers). B.H.E. Jansen collaborates with scholars based in Netherlands, United Kingdom and United States. B.H.E. Jansen's co-authors include André N. Vis, Daniela E. Oprea‐Lager, R. Jeroen A. van Moorselaar, Otto S. Hoekstra, Ronald Boellaard, Jakko A. Nieuwenhuijzen, Maurits Wondergem, Matthijs C. F. Cysouw, Yves J. L. Bodar and Gerben J.C. Zwezerijnen and has published in prestigious journals such as PLoS ONE, The Journal of Urology and Oncotarget.

In The Last Decade

B.H.E. Jansen

27 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.H.E. Jansen Netherlands 12 440 300 94 57 44 30 537
Gianpaolo di Santo Italy 10 358 0.8× 263 0.9× 72 0.8× 76 1.3× 92 2.1× 24 499
Boon Kua Australia 13 527 1.2× 221 0.7× 123 1.3× 71 1.2× 51 1.2× 24 592
Thomas F. Fassbender Germany 10 342 0.8× 228 0.8× 44 0.5× 30 0.5× 37 0.8× 11 389
Sonia Gaur United States 13 735 1.7× 327 1.1× 266 2.8× 27 0.5× 36 0.8× 22 807
Minhaj Siddiqui United States 4 555 1.3× 175 0.6× 200 2.1× 46 0.8× 47 1.1× 14 618
Giorgio Brembilla Italy 15 562 1.3× 293 1.0× 186 2.0× 20 0.4× 52 1.2× 50 684
B. Gruy Austria 5 317 0.7× 221 0.7× 44 0.5× 36 0.6× 31 0.7× 5 384
Jonathan Olivier France 12 369 0.8× 115 0.4× 111 1.2× 29 0.5× 37 0.8× 49 426
Daniele Robesti Italy 8 379 0.9× 81 0.3× 135 1.4× 31 0.5× 59 1.3× 34 442

Countries citing papers authored by B.H.E. Jansen

Since Specialization
Citations

This map shows the geographic impact of B.H.E. Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.H.E. Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.H.E. Jansen more than expected).

Fields of papers citing papers by B.H.E. Jansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.H.E. Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.H.E. Jansen. The network helps show where B.H.E. Jansen may publish in the future.

Co-authorship network of co-authors of B.H.E. Jansen

This figure shows the co-authorship network connecting the top 25 collaborators of B.H.E. Jansen. A scholar is included among the top collaborators of B.H.E. Jansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.H.E. Jansen. B.H.E. Jansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jansen, B.H.E., Stephanie A. Mullane, Bobby K. Joseph, et al.. (2025). Patient‐Centred Web‐Based Information on Head and Neck Squamous Cell Carcinoma: Quality and Readability. Oral Diseases.
2.
Jansen, B.H.E., Remco J.J. Knol, Jakko A. Nieuwenhuijzen, et al.. (2024). Prostate-specific Membrane Antigen Positron Emission Tomography Before Reaching the Phoenix Criteria for Biochemical Recurrence of Prostate Cancer After Radiotherapy: Earlier Detection of Recurrences. European Urology Oncology. 8(2). 417–424. 4 indexed citations
3.
Bodar, Yves J. L., Gerben J.C. Zwezerijnen, B.H.E. Jansen, et al.. (2021). Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study. European Journal of Nuclear Medicine and Molecular Imaging. 49(5). 1731–1742. 18 indexed citations
4.
Bodar, Yves J. L., B.H.E. Jansen, Matthijs C. F. Cysouw, et al.. (2021). SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden. Journal of Nuclear Medicine. 62(9). 1264–1269. 2 indexed citations
5.
Bodar, Yves J. L., B.H.E. Jansen, Gerben J.C. Zwezerijnen, et al.. (2020). Detection of intraprostatic tumor localisation with 18-Fluorine Prostate-Specific Membrane Antigen (PSMA) PET/CT compared to radical prostatectomy specimens: Is PSMA-targeted biopsy feasible? the DeTeCT trial. European Urology Open Science. 19. e470–e471. 1 indexed citations
6.
Jansen, B.H.E., Yves J. L. Bodar, Gerben J.C. Zwezerijnen, et al.. (2020). Prospective evaluation of pelvic lymph node staging with 18fluorine prostate-specific membrane antigen PET/CT prior to extended lymph node dissection in primary prostate cancer – the SALT trial. European Urology Open Science. 19. e1699–e1699. 1 indexed citations
7.
9.
Meijer, Dennie, B.H.E. Jansen, Maurits Wondergem, et al.. (2020). Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer. PLoS ONE. 15(10). e0239414–e0239414. 9 indexed citations
10.
Jansen, B.H.E., Yves J. L. Bodar, Gerben J.C. Zwezerijnen, et al.. (2020). Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -. European Journal of Nuclear Medicine and Molecular Imaging. 48(2). 509–520. 78 indexed citations
11.
Bodar, Yves J. L., B.H.E. Jansen, J. Patrick van der Voorn, et al.. (2020). Detection of prostate cancer with 18F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial. World Journal of Urology. 39(7). 2439–2446. 35 indexed citations
12.
Cysouw, Matthijs C. F., B.H.E. Jansen, Tim van de Brug, et al.. (2020). Machine learning-based analysis of [18F]DCFPyL PET radiomics for risk stratification in primary prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 48(2). 340–349. 103 indexed citations
13.
Jansen, B.H.E., Matthijs C. F. Cysouw, André N. Vis, et al.. (2020). Repeatability of Quantitative 18F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer. Journal of Nuclear Medicine. 61(9). 1320–1325. 22 indexed citations
14.
Wondergem, Maurits, B.H.E. Jansen, Friso M. van der Zant, et al.. (2019). Early lesion detection with 18F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 46(9). 1911–1918. 46 indexed citations
15.
Jansen, B.H.E., Gem Kramer, Matthijs C. F. Cysouw, et al.. (2019). Healthy Tissue Uptake of68Ga-Prostate-Specific Membrane Antigen,18F-DCFPyL,18F-Fluoromethylcholine, and18F-Dihydrotestosterone. Journal of Nuclear Medicine. 60(8). 1111–1117. 21 indexed citations
16.
Jansen, B.H.E., Maqsood Yaqub, Jens Voortman, et al.. (2019). Simplified Methods for Quantification of 18F-DCFPyL Uptake in Patients with Prostate Cancer. Journal of Nuclear Medicine. 60(12). 1730–1735. 27 indexed citations
17.
Jansen, B.H.E., Jakko A. Nieuwenhuijzen, Daniela E. Oprea‐Lager, et al.. (2018). Adding multiparametric MRI to the MSKCC and Partin nomograms for primary prostate cancer: Improving local tumor staging?. Urologic Oncology Seminars and Original Investigations. 37(3). 181.e1–181.e6. 16 indexed citations
18.
Schutte, Tim, B.H.E. Jansen, Robert Rißmann, et al.. (2018). Essential diseases in prescribing: A national Delphi study towards a core curriculum in pharmacotherapy education. British Journal of Clinical Pharmacology. 84(11). 2645–2650. 8 indexed citations
19.
Jansen, B.H.E., et al.. (2018). Local staging with multiparametric MRI in daily clinical practice: diagnostic accuracy and evaluation of a radiologic learning curve. World Journal of Urology. 36(9). 1409–1415. 15 indexed citations
20.
Karanikas, Georgios, et al.. (1998). Technetium-99m-tetrofosmin: a new agent for melanoma imaging?. PubMed. 18(4A). 2759–62. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026